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Eep Confers Lysozyme Resistance to Enterococcus faecalis via the
Activation of the Extracytoplasmic Function Sigma Factor SigV
Sriram Varahan, Vijayalakshmi S. Iyer, William T. Moore, Lynn E. Hancock
Division of Biology, Kansas State University, Manhattan, Kansas, USA
Enterococcus faecalis is a commensal bacterium found in the gastrointestinal tract of most mammals, including humans, and is
one of the leading causes of nosocomial infections. One of the hallmarks of E. faecalis pathogenesis is its unusual ability to toler-
ate high concentrations of lysozyme, which is an important innate immune component of the host. Previous studies have shown
that the presence of lysozyme leads to the activation of SigV, an extracytoplasmic function (ECF) sigma factor in E. faecalis, and
that the deletion of sigV increases the susceptibility of the bacterium toward lysozyme. Here, we describe the contribution of
Eep, a membrane-bound zinc metalloprotease, to the activation of SigV under lysozyme stress by its effects on the stability of the
anti-sigma factor RsiV. We demonstrate that the eep mutant phenocopies the sigV mutant in lysozyme, heat, ethanol, and
acid stress susceptibility. We also show, using an immunoblot analysis, that in an eep deletion mutant, the anti-sigma factor
RsiV is only partially degraded after lysozyme exposure, suggesting that RsiV is processed by unknown protease(s) prior to the
action of Eep. An additional observation is that the deletion of rsiV, which results in constitutive SigV expression, leads to chain-
ing of cells, suggesting that SigV might be involved in regulating cell wall-modifying enzymes important in cell wall turnover.
We also demonstrate that, in the absence of eep or sigV, enterococci bind significantly more lysozyme, providing a plausible ex-
planation for the increased sensitivity of these mutants toward lysozyme.
Enterococcus faecalis is a commensal organism present in themammalian gastrointestinal system (1). Over the past few de-
cades, E. faecalis has arisen as one of the leading causes of nosoco-
mial infection (2). Its role as an opportunistic pathogen is
strengthened by the mobile genetic elements it harbors, which are
often responsible for conferring resistance to a broad range of
antibiotics, including vancomycin (3). In addition, E. faecalis is
known to demonstrate a heightened ability to survive in the pres-
ence of environmental stress factors, such as increased tempera-
ture, acidic pH, and oxidative stress (4). In addition to persistence
in the presence of the aforementioned stress factors, previous
studies have shown that E. faecalis is also highly resistant to ly-
sozyme (5). This high-level resistance to lysozyme (62 mg/ml) is
predominantly attributed to the extracytoplasmic function (ECF)
sigma factor SigV (5). ECF sigma factors are sequestered by mem-
brane-bound anti-sigma factors and rendered inactive in the ab-
sence of a given external stress. Under stress-inducing conditions,
the anti-sigma factors are degraded by membrane and cytosolic
proteases, leading to the activation of ECF sigma factors in a pro-
cess referred to as regulated intramembrane proteolysis (RIP) (6).
RIP has been shown to play an important role in multiple trans-
membrane signaling processes associated with increased virulence
and environmental fitness (7). In Escherichia coli, DegS, a site 1 pro-
tease, and RseP, a site 2 protease, have been shown to degrade the
anti-sigma factor RseA in response to environmental stress, thus me-
diating the release of SigE (8). A similar mechanism is displayed by
Bacillus subtilis, in which PrsW and RasP are the site 1 and site 2
protease, respectively (9). In E. faecalis, neither a site 1 nor a site 2
protease involved in the processing of ECF sigma factors has been
identified to date. The release of SigV from RsiV is thought to require
proteolytic cleavage of RsiV. A candidate site 2 protease was predicted
to be Eep, as it possesses many of the characteristics of membrane-
localized site 2 proteases (10). We hypothesized that Eep would play
an important role in the regulated intramembrane proteolysis of RsiV
leading to the activation of SigV. Here, we show that Eep is essential
for the complete degradation of RsiV, which in turn is essential for the
activation of SigV. Furthermore, the deletion of eep retards the ability
of the SigV regulon to respond to lysozyme and several other stresses,
which likely explains the significant contribution that Eep makes dur-
ing infection (11).
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The pertinent bac-
terial strains and plasmids used in the current study are listed in Tables 1
and 2. Strains were cultured in Todd-Hewitt broth (THB) and grown at
37°C unless otherwise indicated. Escherichia coli ElectroTen-Blue (Strat-
agene, La Jolla, CA) and E. faecalis V583 were used for the maintenance
and propagation of plasmid constructs. ElectroTen-Blue clones were cul-
tured aerobically in Luria-Bertani (LB) broth at 37°C, and E. faecalis V583
and FA2-2-derived strains were cultured in THB at 37°C. The antibiotics
used for selection included chloramphenicol at 10 g ml1 and spectino-
mycin at 150 g ml1 for E. coli and chloramphenicol at 15 g ml1 and
spectinomycin at 500 g ml1 for E. faecalis. Transformation of plasmids
into E. faecalis was done as described previously (12).
Construction of E. faecalis in-frame deletion mutants. In-frame de-
letions of sigV, rsiV, pgdA, and eep individually and the double deletion
mutant of rsiV and eep in E. faecalis were done using plasmids derived
from pLT06 (13), an E. coli enterococcal temperature-sensitive cloning
vector that possesses selectable and counterselectable markers that aid in
the selection of mutants containing the targeted deletions. The primers
used for all the deletions are listed in Table 3. Flanking regions (1 kb)
from both the 5= and 3= ends of sigV, rsiV, pgdA, and eep were PCR am-
plified by using the primers listed in Table 3. For the construction of the
pSV03 plasmid (eep deletion), primers EepP1 and EepP2 were used to
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amplify the 1-kb region flanking the 5= end of eep on the V583 genome.
Primers EepP3 and EepP4 were used to amplify the 1-kb region flanking
the 3= end of the eep region. The EepP1 and EepP2 primers contained
EcoRI and XbaI sites, respectively, and the EepP3 and EepP4 primers
contained XbaI and SphI sites, respectively. Each product was cut with the
respective restriction enzymes and ligated to pLT06 cut with EcoRI and
SphI prior to electroporation into E. coli ElectroTen-Blue cells. Confirma-
tion of the appropriate clones was performed by restriction digest and
sequence analysis. An analogous approach was used for the construction
of pSV15 (sigV deletion), pWM07 (rsiV deletion), and pVI15 (pgdA dele-
tion). Purified plasmids from E. coli cells were electroporated into electro-
competent V583 cells. Strains SV03 (V583 eep), SV07 (V583 sigV),
SV14 (V583 rsiV), and VI50 (V583 pgdA) were generated by following
the protocol as previously described (13). The eep deletion allele was de-
signed such that the first 2 and the last 7 codons remained (98% deleted).
For sigV, the deletion allele consisted of the initial 6 and last 7 codons
(92% deleted). The rsiV deletion allele included the first 6 and last 7
codons (96% deleted), while the pgdA deletion allele possessed the first 3
and the last codon (99% deleted). To create the double deletion of rsiV
and eep, electrocompetent SV03 cells were transformed with pWM07, and
the deletion mutant designated WM02 (V583 eep rsiV) was created
similarly (13). To rule out strain differences associated with V583, we also
TABLE 1 Bacterial strains used in this study
Strain Genotype or description
Reference
or source
V583 Parental strain 48
FA2-2 Parental strain 14
SV03 V583 eep This study
SV05 FA2-2 eep This study
SV07 V583 sigV This study
SV08 SV03(pSV24), complemented eep mutant, Specr This study
SV17 SV03(pSV04), empty vector control, Specr This study
SV09 V583(pSV23), GFP-RsiV fusion, Specr This study
SV10 SV03(pSV23) GFP-RsiV fusion, Specr This study
SV11 V583(pSV14), sigV promoter fusion to lacZ, Specr This study
SV12 SV03(pSV14), sigV promoter fusion to lacZ, Specr This study
SV13 SV07(pSV14), sigV promoter fusion to lacZ, Specr This study
SV14 V583 rsiV This study
SV15 SV14(pSV14), sigV promoter fusion to lacZ, Specr This study
WM01 FA2-2 sigV This study
WM02 V583 eep rsiV This study
VI50 V583 pgdA This study
VI60 V583(pVI16), pgdA promoter fusion to lacZ, Specr This study
VI61 SV03(pVI16), pgdA promoter fusion to lacZ, Specr This study
VI62 SV07(pVI16), pgdA promoter fusion to lacZ, Specr This study
SV16 SV14(pVI16), pgdA promoter fusion to lacZ, Specr This study
TABLE 2 Plasmid constructs used in this study
Plasmid Description Reference
pLT06 Deletion vector, chloramphenicol resistance 13
pSV03 pLT06 containing engineered eep deletion (2-kb EcoRI/PstI fragment) This study
pSV15 pLT06 containing engineered sigV deletion (2-kb EcoRI/PstI fragment) This study
pML28 pAT28 derivative containing the aph promoter 18
pSV17 pML28 derivative containing rsiV with an N-terminal Flag tag This study
pSV23 pSV17 derivative containing a gfp-rsiV fusion under the constitutive aph promoter This study
pTCVLac-Spec Shuttle vector for promoter fusion studies, Ermr Specr 16
pKS12A A derivative of pTCVLac-Spec in which the erythromycin methylase gene was removed by AflII digestion, Specr This study
pMV158GFP gfp-containing plasmid, Tetr 19
pSV04 A derivative of pTCVLac-Spec in which the lacZ and erythromycin methylase genes were removed by SalI
digestion, Specr
This study
pSV24 pSV04 containing full-length eep under the native eep promoter This study
pVI15 pLT06 containing engineered pgdA deletion (2-kb EcoRI/PstI fragment) This study
pWM07 pLT06 containing engineered rsiV deletion (2-kb BamHI/PstI fragment) This study
pSV14 pKS12A containing sigV promoter region (1,234-bp EcoRI/BamHI fragment) This study
pVI16 pKS12A containing pgdA promoter region (1,005-bp EcoRI/BamHI fragment) This study
TABLE 3 Oligonucleotides used in this study
Primer Sequence (5=–3=)a
EepP1 GAGAGGATCCGACATCAATGACACGTTGCC
EepP2 CTCTTCTAGAGTTTTCATAGATGTCCTTCTTC
EepP3 GAGATCTAGAACTTGGAACGATATTCAACGC
EepP4 CTCTGCATGCCCACGAACCAAGACCATTAC
EepUp TCTTTGGTGTACGGAGGACA
EepDown GCATCTTCTTCTGTTGCTTC
Eep 5= GAGAGAATTCACTTTCATGGTAGCACATGTC
Eep 3= CTCTGGATCCCTGTTTCATTAAAACTCTCCTC
SigVP1 GAGAGAATTCGAGCAGATTCGGAACTTTGAG
SigVP2 CTCTGGATCCAACCATCGATTTCTGGAACCT
SigVP3 GAGAGGATCCCTCCGAAGTCTATTGAATTAGT
SigVP4 CTCTCTGCAGCAACTGACTTGGTTAGGTCAG
SigVUp GTCACACATTGGCTTATAAGG
SigVDown GCCACTTCTTCTTCGTTTCC
PgdAP1 GAGAGAATTCGCTTGATTTGCTTGCAGTGC
PgdAP2 CTCTGGATCCATGTCGCATACTTTCACTCCT
PgdAP3 GAGAGGATCCTAGAGCAACTCGGAGCAC
PgdAP4 CTCTCTGCAGGCCACCTTATGATCCAAGAG
PgdAUp TCGCTTGGCTACTGTTGTGC
PgdADown TTGCGAATACTCCTGAAGTAC
RsiVP1 GAGAGGATCCCGGTATCTGTTGTTAATGGTG
RsiVP2 CTTCTTCTAGACCGTTGGCAACGGTTGTTG
RsiVP3 GAGATCTAGATGATTCCTGATCAAGTCATTG
RsiVP4 CTCTCTGCAGCAATGACTTGGTCGTTGCTG
RsiVUp CCGAGGAAGTCCTGCAAGG
RsiVDown TCACTAATGGTAATGGTTGATC
RsiV5= GACTACAAAGACGATGACGACAAGCATATG
GAAGATTTTGTAAAAAGTGTG
RsiV3= CTCTGCATGCGTCGCGTGTTTTTTACTGAGT
GFP5= GAGAGGATCCAAGGAGGAAAAACATATGAGTA
GFP3= CTCTATTAATTTTGTATAGTTCATCCATGCC
FLAGTAG GAGAGGATCCAAGGAGGATTTATAGATGGATT
ATAAGGATCATGATTATAAGGATCATGATAT
CGACTACAAAGACGATGACGACAAG
a The underlined sequences denote restriction sites that were added to the template-
directed sequences to facilitate cloning.
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created deletion mutants for eep and sigV in the FA2-2 (14) strain back-
ground. FA2-2 is a plasmid-free strain derived from the nonhemolytic,
nonproteolytic clinical isolate JH2 (15). FA2-2 was transformed with
pSV03 (eep) and pSV15 (sigV), and following plasmid integration and
excision events, the deletion strains SV05 (FA2-2 eep) and WM01
(FA2-2 sigV) were created.
Complementation of eep deletion mutant. An in-frame eep deletion
in E. faecalis V583 was complemented with full-length eep under the con-
trol of the native eep promoter region in a pSV04 vector background and
was designated pSV24. The eep complement was amplified from the V583
genome with primers Eep5= and Eep3= (Table 3) and subsequently in-
serted as an EcoRI/BamHI fragment into pSV04 cut with EcoRI/BamHI.
To construct pSV04, plasmid pTCVLac-Spec (16) was digested with SalI
and self-ligated to release the SalI fragment containing the lacZ gene.
Plasmid pSV24 was transformed into SV03 (V583 eep), and phenotypic
complementation was confirmed by a lysozyme MIC assay.
MIC assay for determining lysozyme sensitivity. The MICs of ly-
sozyme against strains V583, SV03 (V583 eep), SV07 (V583 sigV),
SV14 (V583 rsiV), VI50 (V583 pgdA), WM02 (V583 eep rsiV), and
SV08 (SV03 with Eep complementation vector), along with FA2-2 and its
isogenic derivatives SV05 (FA2-2 eep) and WM01 (FA2-2 sigV), were
determined by 2-fold serial dilution of a 250-mg/ml lysozyme stock in LB
broth to achieve a series of lysozyme concentrations ranging from 0
mg/ml to 62.5 mg/ml in a 96-well microtiter plate. Briefly, the strains were
grown as standing cultures at 37°C in LB broth overnight to reach station-
ary phase. These overnight cultures (108 CFU/ml) were diluted 1:100 in
fresh LB, and then 100 l was added to 100 l of the LB containing serially
diluted lysozyme such that each well contained an initial inoculum of
105 CFU. The plate was then incubated at 37°C for 24 h before the
results were documented. SV08 (SV03 with eep complementation vector,
pSV24) and SV17 (SV03 with empty vector pSV04) were grown overnight
in the presence of 500 g ml1 spectinomycin for plasmid maintenance.
Settling and chaining assays. V583, SV14 (V583 rsiV), SV03 (V583
eep), SV07 (V583 sigV), and WM02 (eep rsiV) were grown in THB
overnight at 37°C with and without lysozyme at 1 mg/ml and photo-
graphed to observe the settling phenotype, which is indicated by growth of
the bacterium at the bottom of the test tube. The upper layer of the growth
medium becomes transparent as cells settle and grow on the bottom of the
tube. Liquid cultures from the respective strains were also Gram stained
and photographed to observe chaining (Nikon Eclipse 80i with a 100 oil
immersion objective).
Miller assay using strains containing PsigV-lacZ and PpgdA-lacZ re-
porter fusion plasmids. To investigate the transcriptional activity of
known SigV-dependent promoters, we created sigV and pgdA promoter
fusions to a lacZ reporter in plasmid pKS12A, a derivative of pTCV-Lac
Spec (16), in which a small AflII fragment containing the erythromycin
methylase gene was deleted. pSV14 (PsigV-lacZ) and pVI16 (PpgdA-lacZ)
were created by amplifying the promoter regions of sigV with primers
SigVP1 and SigV2 and the pgdA promoter with primers PgdAP1 and
PgdAP2. The promoter regions for both these plasmids were defined
based on the known transcriptional start sites for both sigV and pgdA (4).
These promoters contain the consensus SigV promoter recognition se-
quence (5= TGAAAC-N17-CGTC 3=), and we included an additional
1-kb region (1,188 bp for sigV and 914 bp for pgdA) upstream from the
transcriptional start site to provide additional genetic context for the pro-
moter fusion studies. Primers were engineered with EcoRI and BamHI
restriction sites to facilitate cloning into pKS12A. The resulting vectors,
pSV14 and pVI16, were transformed into strains V583, SV03 (V583
eep), SV07 (V583 sigV), and SV14 (V583 rsiV). The new strains, SV11
[V583(pSV14)], SV12 [SV03(pSV14)], SV13 [SV07(pSV14)], SV15
[SV14(pSV14)], VI60 [V583(pVI16)], VI61 [SV03(pVI16)], VI62
[SV07(pVI16)], and SV16 [SV14(pVI16)], were grown overnight in THB
containing 500 g ml1 spectinomycin at 37°C for plasmid maintenance.
The overnight cultures were diluted 1:100 in sterile THB containing spec-
tinomycin and cultured to reach an optical density at 600 nm (OD600) of
0.5. At this point, cells were induced with lysozyme at a concentration of 1
mg/ml for 30 min. The cultures were then processed to evaluate -galac-
tosidase activity according to the modified Miller assay as described pre-
viously (17). To establish a dose response curve to induction by lysozyme,
SV11 [V583(pSV14)] was exposed to increasing concentrations of lysozyme
(0, 1, 10, 100, and 1,000 g/ml) for 30 min prior to assaying for -galactosi-
dase activity. All assays were repeated three times, and statistical significance
was determined using 1-way analysis of variance (ANOVA).
Temperature, ethanol, and acid challenge assays. In order to deter-
mine the survival of V583, SV03, SV14, WM02, and SV07 under different
stress conditions, the protocol described by Benachour et al. (4) was fol-
lowed. The strains were grown in 5 ml THB medium at 37°C to an OD600
of 0.5 (mid-exponential growth phase). Bacteria were harvested by cen-
trifugation, resuspended in 5 ml of fresh medium, and then exposed to
stresses as follows: (i) for high-temperature heat shock, the cultures were
transferred to 62°C; (ii) for ethanol shock, ethanol was added to a final
concentration of 22% (vol/vol); and (iii) for acid shock, the pH was ad-
justed to 3.2 with 85% lactic acid. Cells were exposed to stress conditions,
and the numbers of surviving bacteria were quantified by plate counting at
0, 1, and 2 h after stress initiation. Assays were repeated three times,
and statistical significance was established using 2-way ANOVA in the
GraphPad 5 software package (Prism, San Diego, CA). The percent sur-
vival shown in the graphs represents the ratio of the number of viable cells
after exposure to stress to the number of cells at time zero prior to chal-
lenge.
CBB staining of whole-cell lysates. Whole-cell extracts of V583,
SV03, and SV07 were prepared by growing strains in THB to an OD600 of
0.7 to 0.8. Lysozyme at a concentration of 1 mg/ml was added to the
cultures for 2 h, the cultures were centrifuged, and the pellet was washed
twice with 1 ml of Tris-EDTA (TE) buffer (pH 8.0). These 1-ml suspen-
sions were lysed using a mini-BeadBeater (BioSpec Products, Bartlesville,
OK) with a 500-l volume of 0.1-mm zirconia beads and a speed setting of
4,800 rpm for 1 min. After brief centrifugation to settle the beads, 5 SDS
loading dye (0.25% bromophenol blue; 50% glycerol; 10% SDS in 0.3 M
Tris-Cl, pH 6.8) was added to the whole-cell lysate, and samples were
boiled at 100°C for 10 min. To normalize the amount of protein loaded
onto the polyacrylamide gel, the whole-cell lysates were also subjected to
Bradford protein assay to determine the protein amounts in each sample.
The same amount of protein was loaded into each well, and the samples
were run at 200 V for an hour and were then subjected to Coomassie
brilliant blue (CBB) staining. Whole-cell lysates from cultures without
lysozyme added and purified lysozyme protein were used as controls.
Immunoblotting to detect RsiV degradation. Plasmid pSV23 ex-
presses the green fluorescent protein (GFP)-RsiV fusion protein and was
constructed in the following manner. The rsiV gene was amplified from
the V583 genome using primers RsiV5= and RsiV3=, which contained an
NdeI and an SphI site, respectively. In a second round of PCR, this prod-
uct was amplified with an additional primer designated FLAGTAG and
with RsiV3=; the resulting product contained an introduced BamHI site
and a Flag tag-encoding sequence at the 5= end. This BamHI- and SphI-
digested product was cloned into the similarly digested pML28 (a pAT28
derivative containing an aph promoter) (18) to create pSV17. We next
swapped the Flag tag for a GFP tag by digesting pSV17 with BamHI and
NdeI. The GFP-encoding region was amplified from pMV158GFP (19)
using primers GFP5= and GFP3=. This PCR product was digested with
BamHI and AseI and ligated to BamHI- and NdeI-digested pSV17 to
obtain pSV23. E. faecalis strains V583 and SV03 were transformed with
pSV23 to create SV09 and SV10, respectively. Cultures of SV09
[V583(pSV23)] and SV10 [SV03(pSV23)] were grown overnight in THB
at 37°C and diluted 1:100 into 10 ml of fresh THB. Cultures were grown to
an OD600 of 0.7 to 0.8, at which point lysozyme was added to a concen-
tration of 1 mg/ml and the cultures were incubated for an additional 2 h.
SV09 and SV10 cultures to which no lysozyme was added were used as
negative controls. All four cultures were centrifuged, and the pellets were
resuspended in 1 ml TE buffer (pH 8.0). Protease inhibitors and EDTA
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were added to these suspensions, and the mixtures subjected to bead beat-
ing in the mini-BeadBeater as described above. The lysates were analyzed
on a 10% SDS–PAGE gel. Following electrophoresis, samples were elec-
trotransferred to a polyvinylidene difluoride (PVDF) membrane and
blotted with rabbit anti-GFP primary antibody (Cell Signaling Technol-
ogy, Inc.) and anti-rabbit horseradish peroxidase (HRP)-conjugated sec-
ondary antibody (Sigma-Aldrich).
RESULTS
Deletion of eep renders E. faecalis more susceptible to lysozyme.
To test whether an eep deletion mutant showed increased suscep-
tibility toward lysozyme compared to the susceptibility of the
wild-type strain, we determined the lysozyme MICs for V583,
SV03, and SV08 (eep complement). The results of this assay are
shown in Table 4. The increased susceptibility of the eep mutant
paralleled that of the sigV mutant, as both displayed MIC values at
5 mg/ml, compared to the 62 mg/ml for V583. When the eep
gene was complemented back into the eep deletion mutant using a
low-copy-number plasmid, the complement strain behaved sim-
ilarly to the wild type, suggesting that the phenotype we observed
was Eep dependent. Consistent with previous observations, the
pgdA deletion mutant did not show any change in lysozyme sus-
ceptibility compared to that of the wild type (20), even though it is
known to be regulated by SigV at the transcriptional level (4, 5).
FA2-2 and mutants lacking eep and sigV in this genetic back-
ground were used as controls in this study to eliminate any strain
bias in the lysozyme resistance mechanism. We observed a similar
reduction in the MIC for the eep and sigV mutants in the FA2-2
strain background compared to the MIC of FA2-2. Finally, as a
proof of principle that Eep acts through RsiV in the activation of
SigV, we deleted rsiV in the eep mutant background and showed
that the lysozyme resistance level of this double mutant paralleled
that of the wild type (62.5 mg/ml).
Eep is essential for the expression of sigV at the transcrip-
tional level. It is known that SigV autoregulates its own expression
(4). We constructed a sigV promoter fusion to lacZ to confirm
these observations and to ascertain the effects of both sigV and eep
deletion on promoter activity. We confirmed that, in wild-type cells
containing the reporter plasmid (SV11), the activity of the sigV pro-
moter is induced by lysozyme in a dose-dependent manner (Fig.
1A). In the experiment whose results are shown in Figure 1B, we
TABLE 4 Lysozyme MIC assay
Strain Lysozyme MIC (mg/ml)
V583 62.5
FA2-2 62.5
SV03 (V583 eep) 5.0
SV07 (V583sigV) 5.0
VI50 (V583 pgdA) 62.5
SV05 (FA2-2 eep) 5.0
WM01 (FA2-2 sigV) 5.0
SV08 [SV03(pSV24)] 62.5
SV17 [SV03(pSV04)] 5.0
WM02 (V583 eep rsiV) 62.5
SV14 (V583 rsiV) 62.5
FIG 1 Qualitative and quantitative measurement of sigV promoter and pgdA promoter activity. (A) sigV-lacZ reporter strain SV11 was subjected to Miller assay
analysis after treatment with increasing concentrations of lysozyme. (B) Spot assay of sigV-lacZ reporter strains SV11, SV12 (eep), and SV13 (sigV) on THB
plates containing 1 mg/ml lysozyme and 80 g/ml X-Gal. (C) Miller assay using LacZ reporter strains SV11, SV12, SV13, and SV15 (rsiV) treated with and
without 1 mg/ml of lysozyme. (D) Miller assay using pgdA-lacZ reporter strains VI60, VI61 (eep), VI62 (sigV), and SV16 (rsiV) treated with and without 1
mg/ml of lysozyme. *, significant difference (P  0.001) relative to wild-type V583 in the presence of lysozyme. Experiments were performed in triplicate, and
error bars represent standard errors of the means (SEM).
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also demonstrated that promoter activity is dependent on a func-
tional SigV, as well as Eep, for the response to lysozyme, as mu-
tants with mutations in eep and sigV remain white in the presence
of lysozyme, whereas the wild-type reporter strain turned blue
on X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside)-
containing agar. Miller assays were performed with the reporter
strains to quantify the amount of -galactosidase protein pro-
duced in the wild type compared to the mutants. SV11 produces
80-fold more -galactosidase activity than the eep and sigV mu-
tants upon lysozyme induction (Fig. 1C). We also analyzed re-
porter strains with the pgdA promoter fusion to lacZ, as the ex-
pression of pgdA was previously shown to be SigV dependent (4).
Similar results were observed in these reporter strains with the
Miller assay (Fig. 1D), as both the eep and sigV mutants displayed
reduced promoter activity compared to that of the parental strain.
Consistent with its known role as an anti-sigma factor, the dele-
tion of rsiV resulted in constitutive expression of both SigV-de-
pendent promoters in the absence of lysozyme induction (Fig. 1C
and D).
Eep confers resistance to other biological stressors. Benach-
our et al. (4) showed that a sigV deletion mutant is attenuated
compared to a wild type when subjected to high-temperature,
low-pH, and ethanol stress conditions. Having established a link
between Eep and SigV phenotypes for lysozyme resistance, we
reasoned that other biological stresses known to impact a sigV
mutant might also negatively affect an eep mutant compared to
their effects on its isogenic parent. We therefore tested the eep and
sigV mutants against a variety of biological stresses (heat, low-pH,
and ethanol stress) and found that the eep mutant phenocopied a
sigV mutant in these biological aspects. Both mutants displayed
nearly 2-log reductions against these stresses compared to the
growth of V583 (Fig. 2). To confirm that the deletion of rsiV in the
eep deletion strain restores the stress tolerance to wild-type levels,
the strain harboring a double deletion of rsiV and eep was also
tested against the aforementioned biological stresses. This strain
showed tolerance to these stresses similar to that of the wild type.
As a control, an rsiV deletion mutant was also used in this study.
This suggests that the deletion of Eep has a direct effect on the
ability of cells to adapt to stress and that this phenotype could be
rescued by the constitutive expression of SigV.
Eep is essential for complete processing of RsiV. Since the
strain that lacked eep phenocopied the strain that lacked sigV in all
the phenotypes tested, our next goal was to determine the exact
role of Eep in the regulated intramembrane proteolysis pathway
leading to the release of SigV. To confirm that Eep is indeed the
site 2 protease, we constructed a plasmid system wherein GFP was
fused to RsiV and introduced into either the parental strain V583
or its isogenic eep mutant (SV03). The image in Figure 3 demon-
strate the results of this experiment, wherein the plasmid-bearing
strains SV09 and SV10 (eep) expressed the 62-kDa GFP-RsiV
fusion protein in the absence of lysozyme stress. When lysozyme
was added, RsiV in the V583 background was completely de-
graded by membrane and cytosolic proteases involved in RIP,
leaving only the 27-kDa GFP protein. The presence of the GFP
protein after SigV activation is likely attributable to the fact that
GFP lacks the recognition domain that is required for Clp protease
degradation of target substrates (21). However, accumulation of
two partially processed GFP-RsiV products predicted to migrate
FIG 2 V583, SV03 (V583 eep), SV14 (V583 rsiV), WM02 (V583 rsiV
eep), and SV07 (V583 sigV) strains were subjected to different stresses. (A)
Strains were subjected to a temperature of 62°C. (B) Strains were subjected to
a pH of 3.2 using 85% lactic acid. (C) Strains were subjected to 22% ethanol
treatment. Strains subjected to lactic acid stress and ethanol stress were incu-
bated at 37°C. Samples were drawn every hour for 2 h, were serially diluted in
sterile PBS (pH 7.4), and plated onto THB agar. V583 eep and V583 sigV
were significantly attenuated compared to the growth of the wild-type (P 
0.001). Experiments were performed in triplicate, and error bars repre-
sent SEM.
FIG 3 Immunoblot analysis. V583 and V583 eep strains containing pSV23
(expresses GFP-RsiV full-length fusion protein under the constitutive aph
promoter) were subjected to 1 mg/ml lysozyme treatment for 30 min after they
were grown to an OD600 of 0.8. Untreated cultures were used as controls. The
whole-cell lysates were transferred to a PVDF membrane and immunoblotted
with rabbit anti-GFP antibodies (Cell Signaling Technology, Inc.). A native
GFP cell lysate was used as a control. The unprocessed GFP-RsiV translational
fusion is predicted to migrate at 62 kDa, whereas the fully processed GFP-RsiV
migrates at the native GFP position (27 kDa). Arrows indicate incompletely
processed GFP-RsiV in the eep mutant exposed to lysozyme.
Eep Contributes to Lysozyme Resistance in Enterococcus
July 2013 Volume 195 Number 14 jb.asm.org 3129
 on June 30, 2014 by U
niversity of K
ansas
http://jb.asm
.org/
D
ow
nloaded from
 
between 34 and 38 kDa was observed when SV10 was treated with
lysozyme.
eep and sigV mutants bind more lysozyme than the wild type.
The enhanced susceptibility of SV03 (eep) and SV07 (sigV)
toward lysozyme led us to believe that these strains might be lack-
ing some crucial mechanism that reduces the accumulation of
lysozyme on the cell surface. The results depicted in Figure 4 dem-
onstrate that the sigV and eep mutants bind more lysozyme than
the wild type. Mass spectrometry analysis was performed to con-
firm that the protein band that was visualized consisted primarily
of lysozyme (data not shown). These data suggest that the hyper-
susceptibility of SV03 and SV07 toward lysozyme is likely due to
the enhanced accumulation of lysozyme on the cell surface of
these mutants.
Constitutive expression of SigV results in a chaining pheno-
type. Interestingly, when the gene encoding RsiV was deleted in
the wild-type and V583 eep genetic backgrounds, a settling phe-
notype of the overnight culture was observed in both strains. The
image in Figure 5 demonstrates this settling phenotype. Gram
staining revealed significant chaining in strains lacking RsiV com-
pared to the chaining in the wild type, suggesting that appropriate
cell wall remodeling is compromised by constitutive expression of
SigV. The chaining phenotype of the rsiV mutant is similar to that
observed for an atlA mutant (22), suggesting that the cell wall
modifications that render E. faecalis more resistant to lysozyme
also perturb the activity of the major autolysin.
Lysozyme induction results in a chaining phenotype. Be-
cause of the chaining phenotype observed in the rsiV mutant, we
reasoned that exposure to lysozyme would induce a chaining phe-
notype that was SigV dependent. To test this prediction, we ex-
FIG 4 SDS-PAGE and Coomassie brilliant blue staining assay. V583, SV03
(eep), and SV07 (sigV) were grown to an OD600 of 0.8 in the presence and
absence of 1 mg/ml lysozyme. Normalized lysates were loaded onto a 12%
polyacrylamide gel and stained with Coomassie brilliant blue dye. Purified
lysozyme (1 g) was added to the left of the marker lane as a control. Arrows
indicate bands corresponding to lysozyme.
FIG 5 Chaining and settling phenotypes. (A) Indicated strains were grown in the presence or absence of 1 mg/ml lysozyme in THB overnight at 37°C and
photographed to depict the settling of the culture on the bottom of the tube. (B) Gram staining was performed on each culture to observe cell chaining.
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posed V583, SV03 (eep), SV07 (sigV), SV14 (rsiV), and
WM02 (eep rsiV) to 1 mg/ml lysozyme and examined the cul-
tures for a settling phenotype.
As predicted, a settling phenotype was observed in the wild
type when the cells were induced with lysozyme, and chaining was
confirmed by Gram staining (Fig. 5). In contrast, the eep and sigV
mutants did not settle or chain in the presence of lysozyme. The
strains containing an rsiV deletion, SV14 (V583rsiV) and WM02
(V583rsiV eep), continued to chain and settle under lysozyme
exposure. This suggests that the activation of SigV leads to the
chaining phenotype and that genes under SigV control are also
likely regulating the activity of the endogenous autolysins of E.
faecalis.
DISCUSSION
In this study, we have shown that Eep is essential for the acti-
vation of SigV, which is an ECF sigma factor that contributes to
lysozyme resistance in E. faecalis via the degradation of the
anti-sigma factor RsiV (5). Eep belongs to a family of mem-
brane-embedded zinc metalloproteases (23). Previous studies
have shown that Eep is involved in the processing of peptide
pheromones (24–26). To the best of our knowledge, this is the
first study that demonstrates an additional role for Eep in the
regulated intramembrane proteolysis of the anti-sigma factor
RsiV leading to the activation of SigV. An eep deletion mutant
phenocopied a sigV deletion mutant and was more than 10-fold
more susceptible to lysozyme than the wild type. Promoter
fusion studies demonstrate that the sigV promoter is inactive in
the absence of Eep. Our hypothesis that Eep is directly involved
in the degradation of RsiV was strengthened by the observation
that the resistance to lysozyme was restored to wild-type levels
in the double mutant (rsiV eep) strain.
In addition, Western blot analysis revealed that Eep is required
for the complete degradation of RsiV. It has been shown that the
activation of other ECF sigma factors (6) in the presence of a
specific stress requires the action of membrane proteases, and the
data from this current study confirm the rationale that Eep is one
such membrane protease. Of note, we were able to detect two
intermediate processed forms of GFP-RsiV in the eep mutant
background. This observation is consistent with the requirement
for multiple RsiV-processing events prior to Eep cleavage. In the
activation of the B. subtilis SigW (an ECF sigma factor), PrsW, a
known site 1 protease, cleaves RsiW (9, 27). Upon cleavage by
PrsW, further processing of RsiW occurs by an as-yet-unidenti-
fied trimming protease activity (28), and this cleavage event pre-
pares RsiW for further processing by the known site 2 protease
RasP.
The data from a Coomassie-stained SDS-PAGE gel indicate
that mutants lacking eep and sigV bind more lysozyme than the
wild type. Previous research has shown that two cell wall-modify-
ing enzymes, O-acetyltransferase (OatA) and the D-alanylation
complex (DltA to DltD [DltA-D]), confer resistance to lysozyme
in B. subtilis and that these genes are directly regulated by SigV
(29). However, in E. faecalis, it has been shown previously that
individual deletion of these genes does not significantly affect the
lysozyme susceptibility of E. faecalis, nor were the oatA and dltA-D
genes shown to be regulated in a SigV-dependent fashion (5). In
our hands, we found that single deletions of both oatA and dltA-D
in the V583 background did not alter the lysozyme resistance of
these strains, as these mutants still showed growth at up to 62.5
mg/ml lysozyme (data not shown). We also examined a double
deletion of both oatA and dltA-D in the V583 background and
found that this strain was only marginally reduced in lysozyme
resistance, to 32 mg/ml (data not shown), which is in contrast to
what was observed by Le Jeune et al. (5), where a double mutant of
oatA and dlt was as sensitive to lysozyme as the sigV mutant in the
JH2-2 genetic background. Whether this difference in lysozyme
susceptibility can be accounted for by strain differences awaits
additional study. It is, however, noteworthy that strain JH2-2 was
derived from the parent strain JH2 by nitrosoguanidine mutagen-
esis (15), and the exposure to the mutagenizing agent may account
for these aberrant strain differences. In contrast, the deletion of
sigV rendered E. faecalis much more sensitive to lysozyme, sug-
gesting that SigV-dependent gene products are involved in mod-
ifying the enterococcal cell wall in a manner independent of
peptidoglycan O-acetylation or teichoic acid D-alanylation. Fur-
thermore, a study by Hébert et al. (30) showed that a mutation in
the gene encoding peptidoglycan deacetylase (pgdA) did not con-
tribute to lysozyme resistance, despite the fact that this gene has
been shown to be regulated in a SigV-dependent manner in E.
faecalis (5). Our present studies also confirmed the absence of a
link between PgdA and lysozyme resistance in E. faecalis V583.
PgdA does, however, contribute to lysozyme susceptibility in
Streptococcus pneumoniae and virulence in animal models of in-
fection (31–33), and recent evidence suggests that PgdA is linked
to virulence in E. faecalis, as a mutant in pgdA was attenuated in a
Galleria mellonella infection model (20). What role PgdA might be
playing in a mammalian host during infection remains to be elu-
cidated. What is also clear from the present study and the addi-
tional cited literature is that SigV contributes to lysozyme resis-
tance in a unique manner, and identifying the SigV regulon will be
of paramount importance in understanding the unusual lysozyme
resistance strategies employed by E. faecalis.
Lysozyme is a naturally secreted antimicrobial agent and is
considered to be part of the innate immune system. It is secreted
by a wide array of organisms in body fluids such as tears, mucus,
and saliva (34–37). A study by Frank et al. (11) showed that Eep is
essential for the pathogenesis of E. faecalis in a rabbit endocarditis
model. It has also been shown that the concentration of lactic acid
is particularly high in the heart (38). One possible explanation as
to why the virulence of an eep deletion mutant was highly at-
tenuated in the endocarditis model is that strains that lack eep
are more susceptible to lactic acid stress, as shown in the pres-
ent study. Another plausible explanation is that strains lacking
eep are more susceptible to lysozyme than wild-type controls
and, hence, are cleared more efficiently by components of the
innate immune system (39, 40). The same idea could poten-
tially be applied to a urinary tract infection (UTI) model due to
the fact that it has been shown that the body responds to uri-
nary tract infection by secreting an increased amount of ly-
sozyme (41–43). It is noteworthy that a sigV mutant of E. faeca-
lis JH2-2 was shown to be attenuated by 1.5 to 2 log in bladder
and kidney colonization compared to the amount of JH2-2,
and an eep mutant of E. faecalis OG1RF is attenuated in a cath-
eter-associated UTI model (5, 44). Collectively, the available
information to date suggests that the virulence associated with
Eep is likely due to its effect on SigV activation. It will be of
interest to establish a link with SigV in endocarditis. It is also
important to note that lysozyme has been shown to be an im-
portant component of the innate immune defense system in
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the gastrointestinal tract (45). Since E. faecalis is a commensal
bacterium which predominantly resides in the gastrointestinal
tract of mammals, it is possible that this bacterium has unique
mechanisms that confer high levels of lysozyme resistance, giv-
ing it a competitive edge in the gastrointestinal tract consor-
tium.
Figure 6 depicts the pathway by which SigV is released from the
anti-sigma factor in the presence of lysozyme. Having evidence
that supports the rationale that Eep is a site 2 protease in the
regulated intramembrane proteolysis pathway, we postulate that
both a site 1 and trimming protease act upstream of Eep cleavage
to initiate the response to lysozyme. The biochemical analysis of
the GFP-RsiV fusion in an eep background exposed to lysozyme
suggests the existence of such proteases, as noted by the interme-
diate forms of GFP-RsiV that accumulate in the immunoblot (Fig.
3). Numerous studies have shown a requirement for site 1 pro-
teases in initiating the activation of ECF sigma factors (6), and
future studies will be aimed at the identification of such a protease.
Following Eep cleavage, the model predicts that RsiV is further
degraded by the cytosolic protease complex ClpXP, as this has
been shown to be essential in the activation of SigW, a known ECF
sigma factor in Bacillus subtilis (46).
Recent work by Ellermeier’s group established that SigV acti-
vation in Bacillus appears to uniquely recognize lysozyme cues
(47, 49), as other cell wall- and membrane-acting agents failed to
induce SigV activation. Work by Le Jeune et al. (5) showed that
nisin does not induce SigV activation in E. faecalis and that the
sigV mutant displays wild-type resistance to nisin, consistent with
lysozyme being a key driver in SigV activation. An unusual finding
from our present study is that both SigV and Eep also contribute
to heat, low-pH, and ethanol stress tolerance. Attempts to use
those conditions to induce SigV activation did not result in detect-
able -galactosidase activity (data not shown), likely because the
reporter protein might have been denatured under the conditions
tested. Conversely, data presented by Benachour et al. (4) corrob-
orate the fact that heat, low-pH and ethanol stress fail to induce
SigV activation, as Northern blots failed to show an increase in
sigV transcript levels following exposure to these stress inducers.
Western immunoblot analysis of SV09 [V583(pSV23)] lysates
subjected to heat, low-pH and ethanol stresses failed to induce the
degradation of RsiV (data not shown). This could be attributed to
the fact that the aforementioned stresses do not strongly induce
the sigV regulon but resistance toward these stresses could still be
SigV dependent. We speculate that a basal level of SigV is required
for activating genes required for tolerance to these stress condi-
tions and that Eep must also contribute to basal levels of SigV
activation. It will be of interest to determine whether the tran-
scriptional profile in the wild type and an isogenic sigV mutant
differ even in the absence of lysozyme induction.
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